Your browser doesn't support javascript.
loading
Special issue "The advance of solid tumor research in China": FGFR4 alterations predict efficacy of immune checkpoint inhibitors in nonsmall cell lung cancer.
Gao, Guanghui; Cui, Longgang; Zhou, Fei; Jiang, Tao; Wang, Wanying; Mao, Shiqi; Wu, Fengying; Jiang, Fangli; Zhang, Bei; Bei, Ting; Xie, Wenchuan; Zhang, Cheng; Zhang, Hougang; Gao, Chan; Zhao, Xiaochen; Bai, Yuezong; Zhou, Caicun; Ren, Shengxiang.
Afiliación
  • Gao G; Department of Medical Oncology, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China.
  • Cui L; 3D Medicines Inc, Shanghai, China.
  • Zhou F; Department of Medical Oncology, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China.
  • Jiang T; Department of Medical Oncology, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China.
  • Wang W; Department of Medical Oncology, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China.
  • Mao S; Department of Medical Oncology, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China.
  • Wu F; Department of Medical Oncology, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China.
  • Jiang F; Department of Gastrointestinal Oncology, Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital & Institute, Beijing, China.
  • Zhang B; 3D Medicines Inc, Shanghai, China.
  • Bei T; 3D Medicines Inc, Shanghai, China.
  • Xie W; 3D Medicines Inc, Shanghai, China.
  • Zhang C; Department of Gastrointestinal Oncology, Key laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital & Institute, Beijing, China.
  • Zhang H; 3D Medicines Inc, Shanghai, China.
  • Gao C; 3D Medicines Inc, Shanghai, China.
  • Zhao X; 3D Medicines Inc, Shanghai, China.
  • Bai Y; 3D Medicines Inc, Shanghai, China.
  • Zhou C; Department of Medical Oncology, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China.
  • Ren S; Department of Medical Oncology, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China.
Int J Cancer ; 152(1): 79-89, 2023 01 01.
Article en En | MEDLINE | ID: mdl-36062503
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_other_respiratory_diseases / 6_trachea_bronchus_lung_cancer Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Antineoplásicos Inmunológicos / Neoplasias Pulmonares Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Int J Cancer Año: 2023 Tipo del documento: Article País de afiliación: China
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_other_respiratory_diseases / 6_trachea_bronchus_lung_cancer Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Antineoplásicos Inmunológicos / Neoplasias Pulmonares Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Int J Cancer Año: 2023 Tipo del documento: Article País de afiliación: China